Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Tax Provisions (2020 - 2025)

Journey Medical (DERM) has disclosed Tax Provisions for 4 consecutive years, with $126000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Tax Provisions rose 869.23% year-over-year to $126000.0, compared with a TTM value of $234000.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $60000.0, down 72.85% over the prior year.
  • Tax Provisions was $126000.0 for Q4 2023 at Journey Medical, up from $95000.0 in the prior quarter.
  • Across five years, Tax Provisions topped out at $8.3 million in Q4 2021 and bottomed at -$3.4 million in Q2 2021.
  • Average Tax Provisions over 4 years is $176454.5, with a median of $23000.0 recorded in 2020.
  • The sharpest move saw Tax Provisions tumbled 14773.91% in 2021, then surged 869.23% in 2023.
  • Year by year, Tax Provisions stood at $23000.0 in 2020, then skyrocketed by 36139.13% to $8.3 million in 2021, then crashed by 99.84% to $13000.0 in 2022, then soared by 869.23% to $126000.0 in 2023.
  • Business Quant data shows Tax Provisions for DERM at $126000.0 in Q4 2023, $95000.0 in Q3 2023, and $13000.0 in Q4 2022.